about
Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responsesPhospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic interventionGenetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles.Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Darapladib: an emerging therapy for atherosclerosis.
@en
Darapladib: an emerging therapy for atherosclerosis.
@nl
type
label
Darapladib: an emerging therapy for atherosclerosis.
@en
Darapladib: an emerging therapy for atherosclerosis.
@nl
prefLabel
Darapladib: an emerging therapy for atherosclerosis.
@en
Darapladib: an emerging therapy for atherosclerosis.
@nl
P2860
P356
P1476
Darapladib: an emerging therapy for atherosclerosis.
@en
P2093
Marshall A Corson
P2860
P304
P356
10.1177/1753944710375820
P577
2010-07-26T00:00:00Z